Annual Accounts Receivable
$0.00
-$398.20 K-100.00%
31 December 2023
Summary:
Biodexa Pharmaceuticals annual accounts receivable is currently $0.00, with the most recent change of -$398.20 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$129.50 thousand (-100.00%). BDRX annual accounts receivable is now -100.00% below its all-time high of $3.02 million, reached on 01 December 2017.BDRX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$2.43 M
+$2.43 M+100.00%
01 June 2024
Summary:
Biodexa Pharmaceuticals quarterly accounts receivable is currently $2.43 million, with the most recent change of +$2.43 million (+100.00%) on 01 June 2024. Over the past year, it has increased by +$1.29 million (+113.42%). BDRX quarterly accounts receivable is now -46.17% below its all-time high of $4.52 million, reached on 01 June 2020.BDRX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDRX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | +113.4% |
| 3 y3 years | -100.0% | +25.6% |
| 5 y5 years | -100.0% | +118.2% |
BDRX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | at high | ||
| 5 y | 5 years | -100.0% | -46.2% | ||
| alltime | all time | -100.0% | -46.2% |
Biodexa Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $2.43 M(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2023 | - | $1.14 M(+186.0%) |
| Dec 2022 | $398.20 K(+794.8%) | $398.20 K(-73.6%) |
| June 2022 | - | $1.51 M(+3287.9%) |
| Dec 2021 | $44.50 K(-65.6%) | $44.50 K(-97.7%) |
| June 2021 | - | $1.94 M(+1395.1%) |
| Dec 2020 | $129.50 K(-90.0%) | $129.50 K(-97.1%) |
| June 2020 | - | $4.52 M(+247.2%) |
| Dec 2019 | $1.30 M | $1.30 M(+16.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $1.11 M(+886.6%) |
| Dec 2018 | $112.90 K(-96.3%) | $112.90 K(-88.0%) |
| June 2018 | - | $940.00 K(-68.8%) |
| Dec 2017 | $3.02 M(+71.9%) | $3.02 M(-10.1%) |
| June 2017 | - | $3.36 M(+91.3%) |
| Dec 2016 | $1.75 M(+20.2%) | $1.75 M(-13.3%) |
| June 2016 | - | $2.02 M(+38.6%) |
| Dec 2015 | $1.46 M(+396.0%) | $1.46 M(-28.2%) |
| June 2015 | - | $2.03 M(+591.1%) |
| Dec 2014 | $294.20 K(+11.5%) | $294.20 K |
| Dec 2013 | $263.80 K | - |
FAQ
- What is Biodexa Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual accounts receivable year-on-year change?
- What is Biodexa Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Biodexa Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of BDRX is $0.00
What is the all time high annual accounts receivable for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual accounts receivable is $3.02 M
What is Biodexa Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, BDRX annual accounts receivable has changed by -$398.20 K (-100.00%)
What is Biodexa Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of BDRX is $2.43 M
What is the all time high quarterly accounts receivable for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high quarterly accounts receivable is $4.52 M
What is Biodexa Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, BDRX quarterly accounts receivable has changed by +$1.29 M (+113.42%)